We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

2 hedge funds and large institutions have $21K invested in Lunai Bioworks in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$13.2K
2
TWA
TCI Wealth Advisors
Arizona
+$6.6K

Top Sellers

No sellers this quarter

LNAI Hedge Fund Activity: Q4 2018 in Review

2 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2018, worth a combined $21K.

Buyers outnumbered sellers: 2 funds opened new LNAI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $13.2K.

  • 2 institutional investors held Lunai Bioworks (LNAI) as of Q4 2018, up from 0 in Q3 2018.
  • Funds reported $21K of Lunai Bioworks stock for Q4 2018.
  • 2 funds opened new Lunai Bioworks positions in Q4 2018 and 0 closed out, a net change of +2 holders.
  • The largest Lunai Bioworks buyer in Q4 2018 was UBS Group, an estimated $13.2K added.

Based on aggregated 13F filings for Q4 2018.